Literature DB >> 16455489

The molecular basis of filamin binding to integrins and competition with talin.

Tiila Kiema1, Yatish Lad, Pengju Jiang, Camilla L Oxley, Massimiliano Baldassarre, Kate L Wegener, Iain D Campbell, Jari Ylänne, David A Calderwood.   

Abstract

The ability of adhesion receptors to transmit biochemical signals and mechanical force across cell membranes depends on interactions with the actin cytoskeleton. Filamins are large, actin-crosslinking proteins that connect multiple transmembrane and signaling proteins to the cytoskeleton. Here, we describe the high-resolution structure of an interface between filamin A and an integrin adhesion receptor. When bound, the integrin beta cytoplasmic tail forms an extended beta strand that interacts with beta strands C and D of the filamin immunoglobulin-like domain (IgFLN) 21. This interface is common to many integrins, and we suggest it is a prototype for other IgFLN domain interactions. Notably, the structurally defined filamin binding site overlaps with that of the integrin-regulator talin, and these proteins compete for binding to integrin tails, allowing integrin-filamin interactions to impact talin-dependent integrin activation. Phosphothreonine-mimicking mutations inhibit filamin, but not talin, binding, indicating that kinases may modulate this competition and provide additional means to control integrin functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455489     DOI: 10.1016/j.molcel.2006.01.011

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  189 in total

Review 1.  Filamins in mechanosensing and signaling.

Authors:  Ziba Razinia; Toni Mäkelä; Jari Ylänne; David A Calderwood
Journal:  Annu Rev Biophys       Date:  2012-02-23       Impact factor: 12.981

2.  SHARPINing integrin inhibition.

Authors:  Mark D Bass
Journal:  Nat Cell Biol       Date:  2011-11-02       Impact factor: 28.824

3.  Cystic fibrosis transmembrane conductance regulator interacts with multiple immunoglobulin domains of filamin A.

Authors:  Martin P Playford; Elisa Nurminen; Olli T Pentikäinen; Sharon L Milgram; John H Hartwig; Thomas P Stossel; Fumihiko Nakamura
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

4.  Spatial coordination of kindlin-2 with talin head domain in interaction with integrin β cytoplasmic tails.

Authors:  Kamila Bledzka; Jianmin Liu; Zhen Xu; H Dhanuja Perera; Satya P Yadav; Katarzyna Bialkowska; Jun Qin; Yan-Qing Ma; Edward F Plow
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

5.  Filamin A controls matrix metalloproteinase activity and regulates cell invasion in human fibrosarcoma cells.

Authors:  Massimiliano Baldassarre; Ziba Razinia; Nina N Brahme; Roberto Buccione; David A Calderwood
Journal:  J Cell Sci       Date:  2012-05-17       Impact factor: 5.285

Review 6.  Filamin structure, function and mechanics: are altered filamin-mediated force responses associated with human disease?

Authors:  Andrew J Sutherland-Smith
Journal:  Biophys Rev       Date:  2011-01-27

7.  Migfilin, a molecular switch in regulation of integrin activation.

Authors:  Sujay Subbayya Ithychanda; Mitali Das; Yan-Qing Ma; Keyang Ding; Xiaoxia Wang; Sudhiranjan Gupta; Chuanyue Wu; Edward F Plow; Jun Qin
Journal:  J Biol Chem       Date:  2008-12-13       Impact factor: 5.157

Review 8.  RSK isoforms in cancer cell invasion and metastasis.

Authors:  Florian J Sulzmaier; Joe W Ramos
Journal:  Cancer Res       Date:  2013-10-04       Impact factor: 12.701

9.  The role of FilGAP-filamin A interactions in mechanoprotection.

Authors:  Yulia Shifrin; Pamela D Arora; Yasutaka Ohta; David A Calderwood; Christopher A McCulloch
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

10.  Filamin A is required for vimentin-mediated cell adhesion and spreading.

Authors:  Hugh Kim; Fumihiko Nakamura; Wilson Lee; Yulia Shifrin; Pamela Arora; Christopher A McCulloch
Journal:  Am J Physiol Cell Physiol       Date:  2009-09-23       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.